Altium Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-305,000
| Closed | -$11.7M | – | 83 |
|
|
2023
Q2 | $11.7M | Hold |
305,000
| – | – | 8.87% | 1 |
|
|
2023
Q1 | $7.06M | Sell |
305,000
-80,000
| -21% | -$1.85M | 3.92% | 4 |
|
|
2022
Q4 | $10.1M | Sell |
385,000
-140,000
| -27% | -$3.67M | 5.13% | 3 |
|
|
2022
Q3 | $10.3M | Sell |
525,000
-90,000
| -15% | -$1.77M | 3.78% | 2 |
|
|
2022
Q2 | $10.8M | Buy |
615,000
+70,000
| +13% | +$1.22M | 4.3% | 1 |
|
|
2022
Q1 | $8.92M | Hold |
545,000
| – | – | 2.98% | 4 |
|
|
2021
Q4 | $8.89M | Buy |
545,000
+80,000
| +17% | +$1.3M | 2.45% | 6 |
|
|
2021
Q3 | $5.93M | Buy |
465,000
+48,433
| +12% | +$618K | 1.56% | 17 |
|
|
2021
Q2 | $5.88M | Buy |
416,567
+210,768
| +102% | +$2.98M | 1.36% | 17 |
|
|
2021
Q1 | $3.2M | Hold |
205,799
| – | – | 0.89% | 45 |
|
|
2020
Q4 | $3.26M | Buy |
+205,799
| New | +$3.26M | 1.22% | 32 |
|